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Objective: To propose an experimental protocol for using high tibial osteotomy (HTO) as a model for studying in
vivo biological effects of large permanent changes in ambulatory load.
Design: This study is a prospective multimodal (clinical, biomechanical, biological) data collection without
randomization. The study will examine a cohort of 40 patients with medial compartment knee OA undergoing
opening wedge HTO.
Experimental protocol: Before planned HTO, patients will be clinically assessed (including mechanical axis mea-
surement from radiographs) and complete questionnaires on physical function. Patients will complete a walking
stress test with blood sampling (30 min walking, 5.5 h sitting), and undergo gait analysis. Six weeks after HTO (at
the time of full weight bearing), the mechanical axis will be measured from radiographs. Patients will complete
the questionnaires and a walking stress test with blood sampling, and undergo gait analysis 6 months after HTO.
The peak external knee adduction moment, knee external knee adduction moment impulse and peak external
knee flexion moment will be used as surrogates of ambulatory load. Load-induced changes in cartilage biomarkers
will be used as surrogates of metabolic changes in response to ambulatory load. At the 12-month follow-up,
subjects will complete the questionnaires.
Conclusion: The results of this study can be considered as proof-of-concept of a potential diagnostic test (walking
stress test) for cartilage degeneration and its prognostic value. A direct relationship between ambulatory load and
cartilage metabolism assessed as degradation to synthesis ratio would allow developing novel load-modifying
interventions and evaluating the efficacy of existing interventions.1. Introduction
Osteoarthritis (OA) is the most common type of arthritis or degen-
erative joint disease [1] and occurs in a substantial portion of the pop-
ulation over the age of 50 [2–4]. Ambulatory load plays an important role
in the development and progression of knee OA [5–7], and high tibial
osteotomy (HTO) is a well-accepted therapy of OA in patients with
malaligned knees [8,9]. In patients with medial compartment knee OA,
individual variations in the mechanics of walking can influence the rate
of progression of knee OA [6] and the outcome of treatment for mediall Orthopaedics and Traumatology
.ch (A. Mündermann).
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International (OARSI). Publishedcompartment OA at the knee [5,10–12]. Moreover, the knee adduction
moment during walking influences the distribution of bone density in the
proximal tibia [13] demonstrating that in vivo biological tissue adapts to
functional loads experienced during walking.
HTO involves realigning the tibia to reduce the load on the medial
compartment of the knee. Most studies on ambulatory load after HTO
have focused on group effects [14–18]. However, patients who adopt a
gait pattern with a low knee adduction moment before HTO and patients
with less severe disease have a better outcome with an HTO and a slower
rate of disease progression [10,12]. Hence, effective load reduction, Spitalstrasse 21, 4031, Basel, Switzerland.
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statically successful HTO to mild valgus. At an average 3.2-year
follow-up, all patients in the low pre-HTO knee adduction moment
group had excellent or good clinical results, while only 50% of the pa-
tients in the high pre-HTO knee adduction moment group had an
excellent or good result [10]. While these results further emphasize the
importance of ambulatory load and that ambulatory load clearly changes
with HTO, the relationship between individual changes, clinical outcome
and the underlying mechanobiological mechanisms are still poorly un-
derstood. Evidence for cartilage regeneration after HTO is scarce [19],
and the biological processes in response to load-altering interventions in
patients with knee OA are poorly understood. Performing a routine
arthroscopy or taking intra-articular biopsies as follow-up methods are
not desirable methods to determine cartilage quality after HTO. Hence,
easier and less invasive methods for determining cartilage regeneration
processes after HTO such as through blood tests would be desirable.
Biomarkers can be considered surrogate measures of tissue health and
metabolism and have the potential to become indicators of normal bio-
logical processes or pathogenic processes. Cartilage oligomeric matrix
protein (COMP) is a prominent constituent of articular cartilage [20].
Serum concentrations of COMP fragments are elevated in patients with
knee OA [21–24], and patients with greater serum COMP concentration
experience a faster progression of their disease [25]. COMPmolecules are
presumably important for maintaining the properties and integrity of the
collagen network [26], contribute to the material properties of biological
tissue [27], and transfer forces from the cartilage matrix to the cell [28].
Thus, COMP may indicate the relationship between biological or path-
ogenic processes and mechanical loading of articular cartilage. COMP is
upregulated following cyclic compression in situ [28] and results of in
vivo studies [29] in competing marathon runners suggested that me-
chanical variations in the way individuals perform the same activity are
related to the differences in the serum COMP levels. Serum COMP levels
increased immediately after a 30-min running exercise but not after slow
deep knee bends or lymphatic drainage in healthy subjects [30] and did
not change after 30-min of mechanical loading of a single osteoarthritic
knee in patients with knee OA [31]. A recent well-controlled study [32]
has demonstrated that the load-induced changes in COMP depend on the
magnitude of ambulatory load. Moreover, in vitro experiments using
explants of porcine cartilage showed that COMP release increased in
proportion to the magnitude of dynamic mechanical stress [33]. The
results of these studies suggest that changes in serum COMP levels
depend on the type of activity, on load magnitude and on cartilage
health. Other potentially mechanosensitive markers are matrix metal-
lopeptidase (MMP)-3, MMP-9 [34], proteoglycan 4 (PRG-4), A dis-
integrin and metalloproteinase with thrombospondin motifs (ADAMTS)
4 and ADAMTS-5 [3537], type II procollagen (CPII) [38], and frag-
ments such as the COL23/4Clong mono epitope (C2C) [39].
The current state of research in the field and of our own research
clearly shows that the mechanism of clinical improvement after HTO is
poorly understood. Previous reports of regenerated articular cartilage
[19] and our results of changes in cartilage biomarker concentrations
after a walking stress test [31,40,41] raise the following questions:
1. Does the functional outcome after HTO correlate with the amount of
reduction in ambulatory load?
2. Are changes in cartilage biomarkers sensitive to the magnitude of
ambulatory load during a walking stress test?
3. Are the changes in physical function related to the amount of
ambulatory load reduction by HTO?
4. Can the effectiveness of reducing load by HTO for regenerating
cartilage be assessed long before the clinical outcome of HTO can be
determined?
In this study, we will use HTO as a model for studying in vivo bio-
logical effects of permanent changes in ambulatory load.22. Materials and methods
2.1. Specific aims
Clearly, there are multiple factors ranging from mechanical to bio-
logical factors that are important to consider. The questions we are
addressing will provide information that help to sort out the processes
underlying HTO and the biological response to ambulatory load in knee
OA. This project will test the overall hypothesis that a sudden ambulatory
load reduction leads to changes in cartilage biology that delay or reverse
osteoarthritic processes representing an in vivo model for assessing
cartilage mechanosensitivity. The following specific aims will be
addressed (Fig. 1):
Specific Aim 1: To test the relationship between changes in ambu-
latory load pre-HTO to 6 months post-HTO, static alignment 6 months
post-HTO and changes in clinical scores pre-HTO to 12months post-HTO.
Hypothesis 1: Reduction in the knee adduction moment will corre-
late more strongly with improvement in clinical scores than post-
operative static alignment.
Previous results [14–18] have shown that the knee adduction
moment decreases and clinical scores improve after HTO. It is expected
that patients with the greatest improvement in clinical scores will have
shown the largest reduction in knee adduction moment during walking
and that change in knee adduction moment is a stronger predictor of
changes in clinical scores than static alignment.
Specific Aim 2: To test the relationship between magnitude of
ambulatory load (modified by HTO) during a walking stress test and the
change in cartilage biomarkers.
Hypothesis 2.1: Load-induced changes in biomarker concentrations
will be smaller after HTO than before HTO. Previous results have shown
that cartilage quality changes after HTO [42,43] and that cartilage bio-
markers are sensitive to a 30-min walking test [31,40,41]. It is possible
that a specific range of loads affect biomarkers for cartilage regeneration
and that smaller or higher loads affect biomarkers for cartilage
degeneration.
Hypothesis 2.2: The magnitude of ambulatory load correlates with
load-induced changes in some but not all biomarkers.
Previous results have suggested that only some biomarkers respond to
changes in load such as during immobilization [44,45]. It is possible that
not all of the tested biomarkers are sensitive to changes in ambulatory
load.
Specific Aim 3: To test the relationship between changes in bio-
markers during a walking stress test 6 months after HTO and functional
outcome 12 months post-HTO.
Hypothesis 3.1: Smaller load-induced increases in serum COMP,
MMP-3 and MMP-9 but not MMP-1 concentrations 6-months post-HTO
correlate with better functional outcome.
Previous results have shown that these COMP, MMP-3 and MMP-9
but not MMP-1 are sensitive to physical activity and exercise and to
unloading during bed rest [44–48]. It is possible that the sensitivity of
metabolic markers to ambulatory load play a role in cartilage regenera-
tion processes after HTO. It is expected that those with the smallest
load-induced changes in COMP, MMP-3 and MMP-9 but not MMP-1 six
months post-HTO will have the best functional outcome 12 months
post-HTO.
Hypothesis 3.2: A smaller load-induced C2C:CPII ratio 6 months
post-HTO correlates with better functional outcome 12 months post-
HTO.
Previous results have shown that a greater degradation/synthesis
ratio has been associated with an increased odds ratio for OA progression
[49] and decreased after load-modifying joint distraction reflecting
cartilage regeneration [19]. To date the effect of load on cartilage
metabolism after HTO has not been established. It is expected that those
with the smallest load-induced C2C:CPII ratio 6 months post-HTO will
have the best functional outcome 12-months post-HTO.
Fig. 1. Illustration of the framework of this study to use HTO as a model for studying in vivo biological effects of sudden large changes in permanent ambulatory load.
This framework allows us to address various research questions. In particular we can study the relation between reduction in ambulatory load and clinical and
functional outcome after high tibial osteotomy (HTO), also in comparison to static alignment correction (Specific Aim 1), we can relate biomarker response and change
in biomarker response to ambulatory load and change in ambulatory load (Specific Aim 2), and finally we can study the relation of biomarker response to good or poor
clinical outcome (Specific Aim 3).
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for analyzing humanmovement to measure ambulatory load, radiographic
assessment for measuring static alignment and enzyme-linked immuno-
sorbent assays (ELISAs) for quantifying biomarker concentrations.
2.2. Study design
This study is a prospective multimodal (clinical, biomechanical,
biological) data collection without randomization.
2.3. Participants
The study will examine a cohort of 40 patients undergoing opening
wedge HTO. The measurement of 40 patients (20 per year) will be realistic
and sufficient for the proposed statistical analysis (see below). The par-
ticipants will be recruited from our orthopaedic clinic by announcing the
project during clinic visits before the planned HTO. The study nurse will be
contacted and inform interested patients about the study.
2.3.1. Inclusion criteria
Patients suffering from radiographically diagnosed and isolated
symptomatic medial compartment knee OA undergoing unilateral
opening wedge HTO (Kellgren-Lawrence [50] grade 2 or 3).
2.3.2. Exclusion criteria
Patients will be excluded from the study for the following criteria: use
of walking aids; inability to walk for 30 min; age <18 years (before
maturation) or age 70 years: due to advanced general sarcopenia
(degenerative loss of muscle mass in aging); body mass index
(BMI) > 35 kg/m2: excessive skin movement influences the gait analysis
(movement between skin mounted marker and underlying bone in-
creases, or locating anatomical landmarks for marker placement not
possible); active rheumatic disorder; prior neuromuscular impairment
(e.g. stroke); conditions other than knee OA that could cause abnormal
patterns of locomotion; prior hip, knee, and ankle prosthesis or osteot-
omy of the lower extremities; prior spine surgery; ligamentous instability
of the knee; other major medical problems; investigators and their im-
mediate families are not permitted to be subjects; persons who have
previously completed or withdrawn from this study; patients currently
enrolled in another experimental (interventional) protocol.32.3.3. Ethical considerations
The testing protocol has been approved by the regional ethics board
(Ethics Committee Northwest Switzerland EKNZ 2015-224) and registered
at clinicaltrials.gov (NCT02622204). Participants in this study will un-
dergo a scheduled HTO that is not subject of this study. Written informed
consent will be obtained by all participants prior to participation.
3. Results – a description of the experimental protocol
Within 4 weeks before the planned HTO, patients with medial
compartment knee OA will be clinically assessed (including mechanical
axis measurement from radiographs) and complete questionnaires on
physical function (Fig. 2). Patients will complete a walking stress test with
blood sampling (30 min walking, 5.5 h sitting), and undergo gait analysis.
Once full load bearing is achieved (6weeks afterHTO), themechanical axis
will be measured from radiographs. Patients will complete the question-
naires and a walking stress test with blood sampling, and undergo gait
analysis 6 months after HTO. At the 12-month follow-up, subjects will
complete the questionnaires. A 12-month follow-up is considered sufficient
for revealing changes in physical function after HTO [8,9].3.1. Medial wedge opening HTO surgical technique
The surgical procedure for the medial wedge opening HTO is similar
to that previously described by Lobenhoffer and Agneskirchner [51].
Two guide pins are placed under fluoroscopic guidance starting 4 cm
distal to the medial tibial plateau angling 1 cm distal to the lateral tibial
plateau and parallel to the sagittal tibial slope. At the anterior tibia
metaphysis, the osteotomy is started 1 cm posterior and parallel to the
tibial tuberosity to protect the tibial tuberosity with its patellar tendon
insertion. The osteotomy is progressed bi-planar below and parallel to the
guide pins. Thin osteotomes are used to complete the osteotomy ending
approximately 1 cm short of the lateral femoral cortex to maintain a
lateral hinge. Larger osteotomes are then used to slowly open the
osteotomy site. A calibrated spreader is then used to open the osteotomy
to the desired correction taking care to leave the tibial slope unchanged.
A Tomofix (Synthes) osteotomy plate is then placed at the anteromedial
tibia spreading the osteotomy site. The osteotomy site is left open in
defects below 10-mm opening and otherwise filled with allograft spongy
bone. Full range of motion as tolerated and 15 kg weight bearing is
Fig. 2. Illustration of the protocol for testing. The walking stress test comprises repeated blood sampling for biomarker assessment before and after a 30-min
walking exercise.
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weeks. Canes are discontinued 6 weeks after the osteotomy, which is the
time for radiographic and clinical check-up.
3.2. Measurements
3.2.1. Clinical assessment
Clinical evaluation will be carried out using the Knee Society Score
(KSS) and its functional component [52] and the Knee Injury and Oste-
oarthritis Outcome Score (KOOS) [53]. The active range of movement
(ROM) of the knee will be measured pre- and postoperatively with a long
arm goniometer.
3.2.2. Radiographic assessment
An anteroposterior weight-bearing radiograph of the knee will be taken
pre-andpostoperatively,andalignmentwillbeexpressedasthefemorotibial
angle (FTA)definedas the lateral anglebetweenthe femoral tibial axes [54].
3.2.3. Walking stress test
Participants will complete a walking stress test pre- and post-
operatively. Blood samples will be obtained immediately before (t0),
immediately after (t1), and 0.5, 1.5, 3.5, and 5.5 h (t2-t5) after a 30-min
walking exercise at self-selected walking speed (walking stress test) on a
instrumented treadmill (mercury® 3p, h/p/cosmos sports & medical
GmbH, Nussdorf-Traunstein, Germany) at least 3 h after waking. For the
walking stress test, inertial sensors (RehaGait®, Hasomed GmbH, Mag-
deburg, Germany) will be attached to the participant's feet to obtain total
number of steps and average walking speed, stride length, and cadence of
the 30-min walking exercise. For the 5.5 h after the walking exercise,
participants will rest while sitting in a chair and their inactivity will be
monitored using an activity monitor (ActiGraph wGT3X-BT, Actigraph,
49 E. Chase St., Pensacola, FL, USA) attached to the participant's waist.
Blood samples (5 ml each) each will be obtained from the same ante-
cubital vein at each evaluation. A professional nurse will place a thin
catheter in a vein of the participant's forearm, which will stay in their
vein for 5.5 h. Samples will be collected and allowed to clot for 30 min.
Serumwill be separated and frozen to20 Cwithin 1 h of collection and
then transferred for storage at 80 C until assayed.
3.2.4. Biological assessment
Serum concentrations of the following biomarkers will be quantified:
3.2.5. Cartilage synthesis
Because type II collagen (CII) is the most abundant protein of cartilage
matrix, the assessment of CII synthesis and degradation has been sug-
gested for evaluating OA severity and progression [55]. CII biosynthesis
can be evaluated by measuring the C-propeptide of type II procollagen
(CPII) [38].
3.2.6. Cartilage degradation
COMP is a structural protein of cartilage and hence specific to carti-
lage in humans [20]. MMP-3 degrades collagen types II, III, IV, IX, and X,4proteoglycans, fibronectin, laminin, and elastin. MMP-9 digests dena-
tured collagen and other substrates, such as type I collagen and aggrecan,
which mainly exist in cartilage [56]. Systemic MMPs may originate from
tissues other than cartilage including the synovium but would still act as
key mediators of catabolic changes in articular cartilage when in contact
with this tissue. Cleavage of type II collagen by collagenases is also
excessive in OA cartilage [57]. The C2C epitope is a fragment resulting
from cleavage of type II collagen by collagenases reflecting degradation
[39].
3.2.7. Assessing serum biomarker concentrations
Serum COMP, MMP-9, MMP-3, C2C and CPII concentrations will be
determined using commercial ELISAs. Investigators will be blinded to the
samples, which will be analyzed in duplicate and in random order. Dif-
ferences due to inter-assay variation will be eliminated by comparing
concentrations within participants and testing all samples of any partic-
ipant on the same plate.
3.2.8. Biomechanical assessment
A nine-camera 3-dimensional motion capture system (Vicon Motion
Systems Ltd., Oxford, UK; frame rate 120 Hz), and two force plates
(Kistler 9260AA6, Kistler Instrumente AG, Winterthur, Switzerland)
will be used to capture kinematic and force data. Reflective skin
markers will be attached to predefined anatomical landmarks and
placed according to the Helen Hayes model for the lower body [58].
Participants will perform a static trial, and the joint coordinate systems
will be defined using the Vicon Plug-in-Gait model (PIG) [59]. Knee
angles will be calculated from the femur and tibia segments. The ankle
angles will be calculated from the tibia and foot segments and hip
angles from the pelvis and femur segments [58]. Kinematic data will
be filtered using a zero-lag quadratic low-pass Butterworth filter with a
cut-off frequency of 12 Hz. Participants will perform three trials at
their self-selected preferred walking speed and at each of three
walking speeds: slow, normal and fast. In addition, at the follow-up
assessment, three trials at the preferred walking speed of the base-
line assessment will be captured to facilitate comparison of data be-
tween time points.
Net joint moments will be calculated by solving motion equations for
the six segments of the lower limbs by incorporating force plate data.
Kinetic data will be filtered using a zero-lag quadratic low-pass Butter-
worth filter with a cut-off frequency of 50 Hz. Joint moments will be
calculated using Newton-Euler inverse dynamics [59] and anthropo-
metric mass distributions taken from the literature [60]. The peak
external knee adduction moment, external knee adduction moment im-
pulse and peak external knee flexion moment will be used as surrogates
of ambulatory load and calculated for each trial.
3.3. Statistical analysis
We will start with an exploration of the individual biomarker
response patterns over time in order to define variables reflecting the
response to the stress test. We will also explore the biomechanical
A. Mündermann et al. Osteoarthritis and Cartilage Open 2 (2020) 100043measurements in order to define a variable reflecting the ambulatory
load. Both initial analyses will be blinded for each other and for all other
study results.
We will correlate the response to the load pre- and post-HTO and the
change in response to the change in load. Further we will consider
regression models to predict functional and clinical outcomes from the
post-HTO load, post biomarker response, change in load, change in
response and static alignment correction. Model comparisons will be
based on R2 values.
The significance level for all statistical tests will be set a priori to 0.05.
3.3.1. Sample size calculation
Assuming that the biomarker response to the walking stress test will
be 20% smaller after compared to before HTO and a standard deviation
of differences of 40% and power of 80%, a sample size of 34 is required to
detect a significant difference at the α ¼ 5% level. Previous data from
healthy subjects have shown that the biomarker response to no load was
200% smaller than for accumulated load with full weight-bearing [40].
Assuming that KOOS scores will increase by 22 with a standard deviation
of 15 [61], and power of 80%, a sample size of 10 is required to detect a
significant difference at the α¼ 5% level. Calculations were performed in
order to detect that if the true correlation has an absolute value 0.50 or
greater, we can reject the null hypothesis that the correlation is less than
0.25. This leads to an R2 of 0.25 or greater. For a power of 80%, a sample
size of 30 is required to detect such a correlation at the α ¼ 5% level (one
sided). The correlation value of 0.50 is conservative and likely un-
derestimates the true relationship between accumulated ambulatory load
and change in biomarker concentration for several reasons. Pilot data
from healthy subjects [62] revealed that the correlation of accumulated
ambulatory load, with measures of cartilage metabolism was 0.831. In
the correlation estimate, within these possible options, a conservative
value of 0.50 was used. These measurements were obtained from a group
of healthy subjects, and the relationships are expected to be stronger in
subjects with knee OA. Given the possibility of unanticipated reasons for
removing subjects, a recruitment plan targeting for 50 subjects should
increase the potential to have sufficient power for this study. If the as-
sociation based on the proposed data is of the same magnitude as that
found in the pilot data, a sample size of 50 will provide at least 80%
power to detect a significant relationship.
4. Discussion
In the proposed study, we will use HTO as a model for studying in
vivo biological effects of large permanent changes in ambulatory load
(Fig. 1). HTO will break the vicious cycle of knee OA progression, varus
malalignment and high ambulatory load. On average, the knee adduction
moment after HTO is reduced to half of pre-operative levels [10]. Hence,
the accumulated load in the affected knee in a post-HTO walking stress
test should also only be half of the pre-HTO accumulated load. Depending
on the specific ambulatory load reduction with HTO, cartilage may have
the capacity to regenerate (sufficient unloading) or further degenerate
(insufficient unloading) leading to poor outcome. Changes in cartilage
biomarkers in response to a walking stress test are expected to change
immediately after the load-altering HTO and depend on the magnitude of
load reduction and be related to clinical outcome at 12-months.
Although the mechanosensitivity of articular cartilage has received
substantial scientific scrutiny, to date in vivo data on the reaction of
articular cartilage to physiological loads in human is limited because of
the inability of measuring biological processes directly. Understanding
these processes is critical for optimizing care for patients with severe
knee OA. Moreover, a model for measuring in vivo mechanosensitivity
may also provide unique insights into in vivo cartilage degeneration and
regeneration processes in healthy subjects, after injuries or in patients
with musculoskeletal disease.
The results of this study can be considered as proof-of-concept of a
potential diagnostic test (walking stress test) for cartilage degeneration5and its prognostic value for future outcomes. In this study we will test if
the magnitude of ambulatory load affects tissue metabolism assessed as
serum biomarker concentrations and if load-induced changes in cartilage
biomarkers are related to functional and clinical outcome of HTO. To
date, the use of cartilage biomarkers for OA diagnostics and prognostics
is limited in part because of the large inter-subject variation in serum
markers. A direct relationship between ambulatory load and cartilage
metabolism assessed as degradation to synthesis ratio would allow
developing novel load-modifying interventions and evaluating the effi-
cacy of existing interventions. Moreover, a predictive relationship be-
tween load-induced changes in cartilage biomarkers 6 months post-HTO
and functional and clinical outcome 6 months later would suggest that
the stress test may be a clinically highly relevant tool for detecting
degenerative cartilage processes. Being able to predict the outcome of
HTO would allow selecting patients who would likely benefit from this
surgical approach.
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